More articles from COMMENTARY

You have access
Compounding Pharmacists, Skills and Knowledge, and the Role of Pharmacy Colleges
Christopher J. Smalley

PDA Journal of Pharmaceutical Science and Technology July 2015, 69 (4) 566-567; DOI: https://doi.org/10.5731/pdajpst.2015.01068
You have access
A Review of the Aging Process and Facilities Topic
Maik W. Jornitz

PDA Journal of Pharmaceutical Science and Technology July 2015, 69 (4) 553-556; DOI: https://doi.org/10.5731/pdajpst.2015.01061
You have access
Risk-based Strategy to Determine Testing Requirement for the Removal of Residual Process Reagents as Process-related Impurities in Bioprocesses
Jinshu Qiu, Kim Li, Karen Miller and Anil Raghani

PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 334-345; DOI: https://doi.org/10.5731/pdajpst.2015.01056
You have access
Emerging Contaminants: A Potential Human Health Concern for Sensitive Populations
Kiranmayi P. Mangalgiri, Ke He and Lee Blaney

PDA Journal of Pharmaceutical Science and Technology March 2015, 69 (2) 215-218; DOI: https://doi.org/10.5731/pdajpst.2015.01034
You have access
The Changing Role of Quality Assurance in the Pharmaceutical Industry
Robert G. Kieffer

PDA Journal of Pharmaceutical Science and Technology July 2014, 68 (4) 313-319; DOI: https://doi.org/10.5731/pdajpst.2014.00987
You have access
The Evolution of Quality by Design (QbD) for Biologics
Anthony R. Newcombe

PDA Journal of Pharmaceutical Science and Technology July 2014, 68 (4) 320-322; DOI: https://doi.org/10.5731/pdajpst.2014.00989
You have access
A Risk-Based Auditing Process for Pharmaceutical Manufacturers
Susan Vargo, Bob Dana, Vijaya Rangavajhula and Stephan Rönninger

PDA Journal of Pharmaceutical Science and Technology March 2014, 68 (2) 104-112; DOI: https://doi.org/10.5731/pdajpst.2014.00954
You have access
Risk-based Process Development of Biosimilars as Part of the Quality by Design Paradigm
Dénes Zalai, Christian Dietzsch and Christoph Herwig

PDA Journal of Pharmaceutical Science and Technology November 2013, 67 (6) 569-580; DOI: https://doi.org/10.5731/pdajpst.2013.00943
You have access
Enabling ICH Q10 Implementation—Part 1. Striving for Excellence by Embracing ICH Q8 and ICH Q9
Nuala Calnan, Kevin O'Donnell and Anne Greene

PDA Journal of Pharmaceutical Science and Technology November 2013, 67 (6) 581-600; DOI: https://doi.org/10.5731/pdajpst.2013.00940
You have access
The Application of Quality Risk Management to the Bacterial Endotoxins Test: Use of Hazard Analysis and Critical Control Points
Carducci Annalaura, Davini Giulia and Ceccanti Stefano

PDA Journal of Pharmaceutical Science and Technology September 2013, 67 (5) 553-567; DOI: https://doi.org/10.5731/pdajpst.2013.00938

Main menu

User menu

Search

More articles from COMMENTARY

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.